Compare AMLX & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMLX | ASTE |
|---|---|---|
| Founded | 2014 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Construction/Ag Equipment/Trucks |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2021 | 2002 |
| Metric | AMLX | ASTE |
|---|---|---|
| Price | $13.90 | $53.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $20.11 | N/A |
| AVG Volume (30 Days) | ★ 867.2K | 198.3K |
| Earning Date | 03-03-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.01% |
| EPS Growth | 65.46 | ★ 784.21 |
| EPS | N/A | ★ 1.68 |
| Revenue | ★ $380,786,000.00 | N/A |
| Revenue This Year | N/A | $15.00 |
| Revenue Next Year | N/A | $4.13 |
| P/E Ratio | ★ N/A | $30.68 |
| Revenue Growth | ★ 1612.94 | N/A |
| 52 Week Low | $3.11 | $29.65 |
| 52 Week High | $17.49 | $64.37 |
| Indicator | AMLX | ASTE |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 48.89 |
| Support Level | $13.36 | $42.84 |
| Resistance Level | $15.37 | $59.99 |
| Average True Range (ATR) | 0.74 | 2.02 |
| MACD | -0.08 | -0.17 |
| Stochastic Oscillator | 48.17 | 70.01 |
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.
Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. The company has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.